Sobi brings in Novo veteran to handle R&D
Sweden’s Sobi and Denmark’s Novo Nordisk are in direct competition with each other on the market for hemophilia treatments, and it also looks like they are targeting the same types of employees.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Co-founder to step down as Chairman of Sweden’s Sobi
For abonnenter
“This is not normal for Novo Nordisk”
For abonnenter